Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn site lets researchers model cell behavior

UConn Health’s Leslie M. Loew, professor of cell biology and computer science and engineering, has received $1.3 million from the National Institutes of Health to...

| By Kelley Gipson

UConn & Yale researchers focus on allergies

Antibodies are large proteins that can grab onto and neutralize disease-causing microorganisms. Sometimes antibodies get confused, and grab onto harmless molecules from things like peanuts...

| By Kelley Gipson

Assembly Biosciences reports Phase 1b dosing

Assembly Biosciences reports the initiation of dosing in a Phase 1b clinical trial to evaluate ABI-M201 (M201) in patients with mildly to moderately active ulcerative...

| By Kelley Gipson

Aeromics founded to control edema

Marc F. Pelletier arrived in New Haven for a postdoctoral fellowship at Yale in 2002, knowing he wanted to form a biotech company “that would...

| By Kelley Gipson

SpringWorks reports progress re neurofibromatosis

SpringWorks Therapeutics reports that the European Commission has granted Orphan Drug Designation for mirdametinib (formerly PD-0325901), an oral, small molecule inhibitor of MEK1 and MEK2,...

| By Kelley Gipson

Genomics firm Sema4 to build lab in Stamford

Genomics-testing firm Sema4 is set to start construction on a 70,000-square-foot lab in the city’s Waterside section, a project that will more than double the...

| By Bill Kelly

UConn researchers record cell communication

Researchers with the University of Connecticut (UConn) School of Dental Medicine developed a technology platform that allows them to record cells communicating in real time....

| By Bill Kelly

SpringWorks in multiple myeloma collaboration

SpringWorks Therapeutics reports that the company has entered into a clinical trial collaboration agreement with GlaxoSmithKline to evaluate SpringWorks Therapeutics’ investigational gamma secretase inhibitor, nirogacestat, in combination...

| By Bill Kelly

Yale researchers investigate metastasis

Yale researchers have discovered how metastasis, or the spread of cancer cells, is triggered on the molecular level. They also developed a way to detect those...